Mimedx Group Inc.

MiMedx Group, Inc. (MDX) applies its patented PURION process to produce high‑performance placental allografts—EpiFix, AmnioFix, EpiCord, AmnioCord, AmnioFill—targeting wound care, burn, surgical and dental markets, with a growing U.S. distributor network.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

Employees: 837
HQ: Marietta

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
MDXG	Mimedx Group Inc. Cap: 0.9B \| P/E: 22.6	EQUITY	NCM	USD	US6024961012	Active	📈